136 related articles for article (PubMed ID: 3961893)
1. Effect of total drug concentration on the free fraction in uremic sera.
Tiula E; Neuvonen PJ
Ther Drug Monit; 1986; 8(1):27-31. PubMed ID: 3961893
[TBL] [Abstract][Full Text] [Related]
2. Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.
Tiula E; Tallgren LG; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):545-52. PubMed ID: 3429058
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseases.
Tiula E; Haapanen EJ; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):469-75. PubMed ID: 3679617
[TBL] [Abstract][Full Text] [Related]
4. Serum protein binding of phenytoin, diazepam and propranolol in age-related decrease in renal function.
Tiula E; Elfving S
Ann Clin Res; 1987; 19(3):163-9. PubMed ID: 3674731
[TBL] [Abstract][Full Text] [Related]
5. Influence of smoking on serum protein composition and the protein binding of drugs.
Benedek IH; Blouin RA; McNamara PJ
J Pharm Pharmacol; 1984 Mar; 36(3):214-6. PubMed ID: 6144765
[TBL] [Abstract][Full Text] [Related]
6. Elevated free fosphenytoin concentrations in uremic sera: uremic toxins hippuric acid and indoxyl sulfate do not account for the impaired protein binding of fosphenytoin.
Dasgupta A; Havlik D
Ther Drug Monit; 1998 Dec; 20(6):658-62. PubMed ID: 9853983
[TBL] [Abstract][Full Text] [Related]
7. Variations in drug free fraction during alcohol withdrawal.
Sandor P; Naranjo CA; Khouw V; Sellers EM
Br J Clin Pharmacol; 1983 Apr; 15(4):481-6. PubMed ID: 6849785
[TBL] [Abstract][Full Text] [Related]
8. A major inhibitor of phenytoin binding to serum protein in uremia.
Mabuchi H; Nakahashi H
Nephron; 1988; 48(4):310-4. PubMed ID: 3362278
[TBL] [Abstract][Full Text] [Related]
9. Temperature dependence of phenytoin-protein binding in serum: effects of uremia and hypoalbuminemia.
Allison TB; Comstock TJ
Ther Drug Monit; 1988; 10(4):376-81. PubMed ID: 3201522
[TBL] [Abstract][Full Text] [Related]
10. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
Odar-Cederlöf I; Borga O
Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
[TBL] [Abstract][Full Text] [Related]
11. Phenytoin-oxacillin interactions in normal and uremic sera.
Dasgupta A; Sperelakis A; Mason A; Dean R
Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332
[TBL] [Abstract][Full Text] [Related]
12. Drug protein binding in chronic renal failure: evaluation of nine drugs.
Vanholder R; Van Landschoot N; De Smet R; Schoots A; Ringoir S
Kidney Int; 1988 May; 33(5):996-1004. PubMed ID: 3392889
[TBL] [Abstract][Full Text] [Related]
13. Unexpected suppression of free phenytoin concentration by salicylate in uremic sera due to the presence of inhibitors: MALDI mass spectrometric determination of molecular weight range of inhibitors.
Biddle DA; Wells A; Dasgupta A
Life Sci; 2000; 66(2):143-51. PubMed ID: 10666010
[TBL] [Abstract][Full Text] [Related]
14. Increased free phenytoin concentrations in predialysis serum compared to postdialysis serum in patients with uremia treated with hemodialysis. Role of uremic compounds.
Dasgupta A; Abu-Alfa A
Am J Clin Pathol; 1992 Jul; 98(1):19-25. PubMed ID: 1615921
[TBL] [Abstract][Full Text] [Related]
15. In vitro displacement of phenytoin from protein binding by nonsteroidal antiinflammatory drugs tolmetin, ibuprofen, and naproxen in normal and uremic sera.
Dasgupta A; Timmerman TG
Ther Drug Monit; 1996 Feb; 18(1):97-9. PubMed ID: 8848829
[TBL] [Abstract][Full Text] [Related]
16. A pressure ultrafiltration method for serum free drug determination. Comparison with equilibrium dialysis using normal and uraemic sera.
Tiula E
Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):51-5. PubMed ID: 6717171
[TBL] [Abstract][Full Text] [Related]
17. Correction of protein binding defect in uremic sera by charcoal treatment.
Craig WA; Evenson MA; Sarver KP; Wagnild JP
J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
[TBL] [Abstract][Full Text] [Related]
18. Drug binding in sera deficient in lipoproteins, albumin or orosomucoid.
Pike E; Kierulf P; Skuterud B; Bredesen JE; Lunde PK
Br J Clin Pharmacol; 1983 Sep; 16(3):233-9. PubMed ID: 6626414
[TBL] [Abstract][Full Text] [Related]
19. Interference in immunoassay measurements of total and free phenytoin in uremic patients: a reappraisal.
Roberts WL; Rainey PM
Clin Chem; 1993 Sep; 39(9):1872-7. PubMed ID: 8375063
[TBL] [Abstract][Full Text] [Related]
20. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
Lai CM; Moore P; Quon CY
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
